Shore is focused on partnering with healthcare companies in the lower middle market.
Profitable healthcare businesses in North America with approximately $5 – $50 million in revenue and $1 – $7 million in EBITDA
Greater than $1 million in revenue. No minimum EBITDA requirements
Family succession transactions, Management buyouts, Leveraged buyouts, Recapitalizations, Industry consolidations, Growth investments, Corporate divestitures
Active Areas of Focus: